Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185900 · ClinicalTrials.gov registry record · NA
Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
NCT00185900: Completed NA study, sponsored by Stanford University.
NCT00185900 is a NA study that has completed, run by Stanford University. The registered enrollment target is 192 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185900, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
Study Summary
To compare intravenous magnesium sulfate to oral nifedipine for acute tocolysis of preterm labor
Interventions
- DRUG Nifedipine
- DRUG Magnesium Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 1999-04 |
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185900
The ClinicalTrials.gov registry entry for NCT00185900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nifedipine is the first listed.
NCT00185900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00185900 about?
NCT00185900 is a clinical study titled "Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial". To compare intravenous magnesium sulfate to oral nifedipine for acute tocolysis of preterm labor
What is the current status of trial NCT00185900?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 1999-04. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00185900?
The interventions under investigation include: Nifedipine (DRUG), Magnesium Sulfate (DRUG).
Who is sponsoring clinical trial NCT00185900?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.